| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/06/2011 | CN101843872B Chinese medicinal composition for treating turbid urine and preparation method thereof |
| 07/06/2011 | CN101693010B Cefathiamidine prosoma liposome preparation |
| 07/06/2011 | CN101653571B Traditional Chinese medicine for curing urinary system diseases |
| 07/06/2011 | CN101607060B Traditional Chinese medicine for treating urination incontinence |
| 07/06/2011 | CN101198614B Thienopyrimidine derivative |
| 07/06/2011 | CN101119986B Optically active tetrahydronaphthalene derivative |
| 07/06/2011 | CN101048408B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/05/2011 | US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | CA2689080C Treating benign prostate hyperplasia with sarms |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/05/2011 | CA2459172C Bicyclic compound, production and use thereof |
| 06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011077800A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
| 06/30/2011 | WO2011077712A1 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011077711A1 Novel 2-pyridone derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011076811A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/30/2011 | WO2011019963A3 Prg4 treatment for interstitial cystitis |
| 06/30/2011 | US20110160300 Renin Inhibitors and Methods of Use Thereof |
| 06/30/2011 | US20110160243 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 06/30/2011 | US20110160235 Triazolyl tropane derivatives |
| 06/30/2011 | US20110160205 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 06/30/2011 | US20110160201 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160161 Concentrated therapeutic phospholipid compositions |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110159094 Extended release compositions for high solubility, high permeability active pharmaceutical ingredients |
| 06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
| 06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | US20110158947 Sulfonylurea receptor and means for treating ischaemia |
| 06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | CA2783704A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/29/2011 | EP2338976A1 Lactic acid bacterium having high oxalic acid decomposition ability |
| 06/29/2011 | EP2338899A1 Peptides for activation and inhibition of delta PKC |
| 06/29/2011 | EP2338887A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2041094B1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 06/29/2011 | EP1503788B1 Treatment of alpha-galactosidase a deficiency |
| 06/29/2011 | EP1124567B2 Buffered compositions for dialysis |
| 06/29/2011 | CN201881930U Automobile seat cushion |
| 06/29/2011 | CN102112221A Adsorbent, cleansing agent, remedy for kidney disease and functional food |
| 06/29/2011 | CN102106980A Medicament for treating uremia and preparation method thereof |
| 06/29/2011 | CN102106978A Medicament for treating nephritis |
| 06/29/2011 | CN102106959A Traditional Chinese medicine for treating nephropathy |
| 06/29/2011 | CN102106956A Method for controlling quality of Shenbao mixture percolating fluid |
| 06/29/2011 | CN102106939A Quality control method for extract concentrated liquor of condensed pills of six ingredients with rehmannia root |
| 06/29/2011 | CN102106938A Plant extract for treating gout and kidney disease and preparation method thereof |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106880A Method for preparing injection liquid for treating infection of digestive systems and urinary systems of animals |
| 06/29/2011 | CN102106841A Tamsulosin hydrochloride preparation and preparation method thereof |
| 06/29/2011 | CN102106813A Sodium new neohouttuyfonate injection and preparation method and application thereof |
| 06/29/2011 | CN102106420A Method for processing camellia nitidissima granules |
| 06/29/2011 | CN101912581B Chinese medicinal composition for treating cholecystitis and calculosis and preparation method thereof |
| 06/29/2011 | CN101869645B Jinkui kidney qi-replenishing traditional Chinese medicine solid oral preparation and preparation method thereof |
| 06/29/2011 | CN101843787B Chinese medicament for treating benign prostatic hyperplasiabrain |
| 06/29/2011 | CN101711827B Traditional Chinese medicine preparation for clearing heat, cooling blood and nourishing yin and kidneys, preparation method and detection method thereof |
| 06/29/2011 | CN101700326B Preparation method of traditional Chinese medicine preparation for clearing heat and promoting urination for treating stranguria |
| 06/29/2011 | CN101695560B Chinese medicinal composition for treating concrement |
| 06/29/2011 | CN101693045B Effective portion of conical hydrangea, preparation method thereof, and composition and usage thereof |
| 06/29/2011 | CN101623457B Traditional Chinese medicine for treating chronic prostatitis |
| 06/29/2011 | CN101618133B Application of yang-reinforcing kidney-protecting medicine in preparing medicine preventing and treating osteoporosis |
| 06/29/2011 | CN101618059B Preparation method and medical application of cynoglossum zeylanicum total phenolic acid |
| 06/29/2011 | CN101607076B Traditional Chinese medicine for treating uraemia |
| 06/29/2011 | CN101579411B Medicinal dripping pill for treating prostatauxe |
| 06/29/2011 | CN101244217B Medicament for treating kidney disease |
| 06/29/2011 | CN101124249B Human monoclonal antibodies to prostate specific membrane antigen(PSMA) |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968528 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2464002C Pacap compositions and methods for tumor imaging and therapy |
| 06/23/2011 | WO2011075636A2 Wise binding agents and epitopes |
| 06/23/2011 | WO2011075578A1 Methods of treating interstitial cystitis |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152367 Process for the preparation of fesoterodine with low impurities content |
| 06/23/2011 | US20110152326 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
| 06/23/2011 | US20110152325 Carboxamide compounds and their use as calpain inhibitors iv |
| 06/23/2011 | US20110152318 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 06/23/2011 | US20110152316 3,4-substituted piperidine derivatives as renin inhibitors |
| 06/23/2011 | US20110152315 Compounds for the treatment of metabolic diseases |
| 06/23/2011 | US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 06/23/2011 | US20110152283 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use |
| 06/23/2011 | US20110152272 Treatment Of Incontinence |
| 06/23/2011 | US20110152265 Carboxamide compounds and their use as calpain inhibitors v |
| 06/23/2011 | US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor |
| 06/23/2011 | US20110152250 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152227 Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof |
| 06/23/2011 | US20110152223 Therapeutic agent for anca-related vasculitis |
| 06/23/2011 | US20110152217 Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol |